3812 results for «218»
3812 results
Multiple VHD: a diagnostic and clinical challenge
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult these presentations on multiple VHD to learn how to deal with combined valvular lesions, how to assess their severity and how to treat them.
Mixed VHD: how to manage?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn more about aortic stenosis and aortic regurgitation: how to diagnose these conditions, how to select patients for surgical or transcatheter interventions, and how to treat them.
Endocarditis: what can we suggest for the upcoming ESC guidelines?
11 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn more about the various challenges in treating patients with endocarditis, to understand how to better diagnose valve endocarditis and to discover new transcatheter interventions after endocarditis.
The challenge of aortic regurgitation: better imaging for better clinical practice
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Watch this session to learn about the challenges of diagnosing aortic regurgitation and how to overcome them, to better understand the right timing for intervention based on available evidence, and to discover what tools exist to more accurately assess the severity of aortic regurgitation.
How should I treat a blue baby - A patient's journey
03 Mar 2023 – From AfricaPCR 2023
Consider the very specific case of a female newborn whose predictive diagnosis suggested two leads: newborn transient tachypnea vs neonatal sepsis, and analyze how this little patient was managed, from birth to final treatment.
Coronary clinical cases - session 3
04 Mar 2023 – From AfricaPCR 2023
Among the 6 presentations offered in this AfricaPCR 2023 session, find out more about a multivessel PCI and tight aortic stenosis, the case of a 6-year-old boy with HTN and dilated cardiomyopathy, a hybrid SVG calcium modification, and rare complications in a TAVI case.
Matching patient to TAVI prosthesis - Is there a better way?
04 Mar 2023 – From AfricaPCR 2023
In this AfricaPCR 2023 session, analyse several complex TAVI cases and explore why and how THV design elements should help optimise TAVI clinical outcomes.
AfricaPCR 2023: Opening Ceremony
03 Mar 2023 – From AfricaPCR 2023
After 3 years without a physical Course, it is with great pleasure that the speakers open this new edition of AfricaPCR. They begin by recalling the values of this Course and presenting its Directors, then they unfold the programme by underlining the strong points and also...
AfricaPCR 2023: Closing Ceremony
04 Mar 2023 – From AfricaPCR 2023
Beyond all the thanks that should naturally be expressed at the time of closing this new edition of AfricaPCR, this closing ceremony is also an opportunity to remind that the contents of this course remain available on our platforms and social networks, and that the appointment...
A new percutaneous technique for effective vascular access site closure in patients undergoing TAVI and thoraco-abdominal aortic aneurysm repairs
09 Jan 2019
Results of the PASTE study
Authors :
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/whats-new-on-pcronline/2025/esc/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!
17 Oct 2020
PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.
Author
